Quantum Biotechnology (China) Co., Limited Company Information

Current Status : Live


Quantum Biotechnology (China) Co., Limited's Hong Kong CR Number is 2524451. Incorporation Date is 07-APR-2017. It's Winding up Mode is . Dissolution date is . Quantum Biotechnology (China) Co., Limited company is of Private company limited by shares Type.
Additional Remarks on the Quantum Biotechnology (China) Co., Limited company are .

Company Data

CRN2524451
Company NameQUANTUM BIOTECHNOLOGY (CHINA) CO., LIMITED
Chinese Name量子生物科技(中國)有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation07-APR-2017
See companies with same Incorporation Date - 07-APR-2017
Date of Dissolution
Remarks
Important Note
Tagsquantum   biotechnology   china   co   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
QUANTUM BIOTECHNOLOGY (CHINA) CO., LIMITED07-APR-2017

FAQs:

When was Quantum Biotechnology (China) Co., Limited incorporated?

Quantum Biotechnology (China) Co., Limited was incorporated on 07-APR-2017 in Hongkong.

What is the type of Quantum Biotechnology (China) Co., Limited?

Quantum Biotechnology (China) Co., Limited is classified as Private company limited by shares.

What is the current status of Quantum Biotechnology (China) Co., Limited Company?

The status of Quantum Biotechnology (China) Co., Limited is Live.

What is the CR Number of Quantum Biotechnology (China) Co., Limited?

The CR Number of Quantum Biotechnology (China) Co., Limited is 2524451.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Quantum Biotechnology (China) Co., Limited. The official registry should always be referred for latest information.

Last Updated on 25-05-2017.

Check other companies added on 25-05-2017

Check out Companies Incorporated on 07-APR-2017: